|
|
Blood, 15 May 2007, Vol. 109, No. 10, pp. 4351-4359.
Prepublished online as a Blood First Edition Paper on January 23, 2007; DOI 10.1182/blood-2006-09-047563.
Previous Article | Next Article 
Submitted September 18, 2006
Accepted January 12, 2007
Activation of MAP kinase p38 is critical for the cell cycle
controlled suppressor function of regulatory T cells
Henric S. Adler, Sebastian Kubsch, Edith Graulich, Stephan Ludwig, Juergen Knop, and Kerstin Steinbrink*
Dept of Dermatology, University of Mainz, Germany
Institute of Molecular Virology, University of Muenster, Germany
* Corresponding author; email: steinbrink{at}hautklinik.klinik.uni-mainz.de.
Regulatory T cells play an essential role in the control of self tolerance and processes of adaptive immunity. Tolerogenic IL-10-modulated human dendritic cells (IL-10DCs) induce anergic T cells with strong suppressive properties (iTregs) that inhibit the activation of effector T cells. In this study, we evaluated the interaction between cell cycle regulation and intracellular signaling in these iTregs. Analysis of signal transduction events revealed a downregulation of the mitogen-activated protein kinases (MAPKs) JNK and a non-activation of ERK in contrast to a marked activation of p38 MAPK and the p38 effector MAPK-activated protein kinases 2/3 (MAPKAP2/3). The elevated activation of p38 is critical for the induction and maintenance of anergy controlled by an increased expression of the cell cycle inhibitor p27Kip1. Moreover, blocking experiments with the specific inhibitor SB203580 demonstrated that the regulatory function of iTregs is associated with an enhanced p38 MAP kinase activity. In contrast to other Treg populations, the suppressor function of iTregs is independent of IL-10. In conclusion, our data indicate that a cross talk of cell cycle regulation and p38 dependent signal transduction is required for the suppressor function of iTregs.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Yessoufou, A. Ple, K. Moutairou, A. Hichami, and N. A. Khan
Docosahexaenoic acid reduces suppressive and migratory functions of CD4CD25 regulatory T-cells
J. Lipid Res.,
December 1, 2009;
50(12):
2377 - 2388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gabrysova, K. S. Nicolson, H. B. Streeter, J. Verhagen, C. A. Sabatos-Peyton, D. J. Morgan, and D. C. Wraith
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells
J. Exp. Med.,
August 3, 2009;
206(8):
1755 - 1767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Zhao, C. Falk, W. Osen, M. Kato, D. Schadendorf, and V. Umansky
Activation of p38 Mitogen-Activated Protein Kinase Drives Dendritic Cells to Become Tolerogenic in Ret Transgenic Mice Spontaneously Developing Melanoma
Clin. Cancer Res.,
July 1, 2009;
15(13):
4382 - 4390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. V. Lourenco, C. Procaccini, F. Ferrera, N. Iikuni, R. P. Singh, G. Filaci, G. Matarese, F.-D. Shi, E. Brahn, B. H. Hahn, et al.
Modulation of p38 MAPK Activity in Regulatory T Cells after Tolerance with Anti-DNA Ig Peptide in (NZB x NZW)F1 Lupus Mice
J. Immunol.,
June 15, 2009;
182(12):
7415 - 7421.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|